US Judge Margo Brodie of the Eastern District of New York has ordered GPB Capital into receivership. This begins the process of the remaining assets being distributed to the investors. The Receivership […]
Mitch Brisker and Jeffrey Augustine discuss recent events concerning the The Nation of Islam, Scientology, Hate Speech, Censorship, Fair Game, and Lawsuits.
California PI and Scientology critic Jeffrey Augustine discusses Scientologist and Nation of Islam leader Louis Farrakhan and his recently filed lawsuit against the ADL and the Simon Wiesenthal Center. Farrakhan is seeking […]
Even as he had released his book Dianetics: The Modern Science of Mental Health on May 9, 1950, L. Ron Hubbard was still very much a 19th century spiritualist and occultist. As […]
We recently published Monica Eaton’s statement that she is not a Scientologist and has not been a member of the Church of Scientology since 2006. We congratulate Monica Eaton for taking this […]
November 24, 2008: Fifteen years ago today, former Scientologist Mario Majorski, 48, drove a rented Corvette down from his home in Florence, Oregon to Los Feliz, California where the Scientology Celebrity Centre […]
Video: The Evolution of David Miscavige from L. Ron Hubbard’s Camera Boy to Scientology’s Weird Cult Leader
Mitch Brisker and Jeffrey Augustine discuss the evolution of David Miscavige from L. Ron Hubbard’s camera boy to Scientology’s weird Cult Leader.
Scientology just announced an “Ultimate Scientology Weekend” scheduled for December 15-17, 2023. Jeffrey Augustine takes viewers on a guided tour of what Scientologists can expect from this event. As usual, what Scientology […]
The Scientology Money Project is issuing the following clarification and correction based upon its receipt of verified information: “Monica Eaton, CEO of Chargebacks911, has not held membership, affiliation, or made any financial […]
Scientology Billionaire Bob Duggan Paid a Chinese Pharma Firm $500 Million & And Now He Wants the Money Back!
Bob Duggan loaned his company Summit Therapeutics ~$500 million to allow the firm to purchase the rights to an investigational drug called Ivonescimab in the US, the UK, and other countries. The […]